DR REDDYS LABORATORIES LTD
About DR REDDYS LABORATORIES LTD
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Market cap
- $11.0B
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $11.0B
- Dividend yield
- 0.63%
- Shares outstanding
- 833.1M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Apr 11, 2001
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Trading 18% below its 52-week high.
- Pays a dividend yielding about 0.63% annually.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review DR REDDYS LABORATORIES LTD.
Write a review
News about DR REDDYS LABORATORIES LTD
News & sentiment via Polygon.io
